93 related articles for article (PubMed ID: 31932555)
1. Farnesoid X receptor and liver X receptors regulate Oct3/4 expression by multiple feedback regulating system in normal renal-derived cells and renal adenocarcinoma cells.
Fujino T; Sugizaki K; Kato R; Beppu M; Murakami S; Lee H; Oshima T; Hayakawa M
J Toxicol Sci; 2020; 45(1):25-35. PubMed ID: 31932555
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line.
Fujino T; Sakamaki R; Ito H; Furusato Y; Sakamoto N; Oshima T; Hayakawa M
J Toxicol Sci; 2017; 42(3):259-265. PubMed ID: 28496032
[TBL] [Abstract][Full Text] [Related]
3. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
[TBL] [Abstract][Full Text] [Related]
4. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.
Xu G; Pan LX; Li H; Shang Q; Honda A; Shefer S; Bollineni J; Matsuzaki Y; Tint GS; Salen G
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G730-5. PubMed ID: 14684380
[TBL] [Abstract][Full Text] [Related]
5. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
Redinger RN
Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
7. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor-alpha gene expression is positively regulated by thyroid hormone.
Hashimoto K; Matsumoto S; Yamada M; Satoh T; Mori M
Endocrinology; 2007 Oct; 148(10):4667-75. PubMed ID: 17628006
[TBL] [Abstract][Full Text] [Related]
9. Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR.
Dong B; Singh AB; Guo GL; Young M; Liu J
Int J Mol Med; 2019 May; 43(5):1927-1938. PubMed ID: 30896855
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
[TBL] [Abstract][Full Text] [Related]
11. Bile acid regulation of gene expression: roles of nuclear hormone receptors.
Chiang JY
Endocr Rev; 2002 Aug; 23(4):443-63. PubMed ID: 12202460
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha.
Tobin KA; Steineger HH; Alberti S; Spydevold O; Auwerx J; Gustafsson JA; Nebb HI
Mol Endocrinol; 2000 May; 14(5):741-52. PubMed ID: 10809236
[TBL] [Abstract][Full Text] [Related]
13. The nuclear receptor LXR is a glucose sensor.
Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
[TBL] [Abstract][Full Text] [Related]
14. Nuclear receptors and cholesterol metabolism in the intestine.
Moschetta A
Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
[TBL] [Abstract][Full Text] [Related]
15. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.
Eckert GP; Vardanian L; Rebeck GW; Burns MP
Neurosci Lett; 2007 Aug; 423(1):47-52. PubMed ID: 17662526
[TBL] [Abstract][Full Text] [Related]
16. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
17. Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease.
Ahn SB; Jun DW; Jang K; Lee BH; Shin KJ
Korean J Intern Med; 2019 Jul; 34(4):777-784. PubMed ID: 29466845
[TBL] [Abstract][Full Text] [Related]
18. LXR agonists for the treatment of atherosclerosis.
Jaye M
Curr Opin Investig Drugs; 2003 Sep; 4(9):1053-8. PubMed ID: 14582448
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide suppresses liver X receptor β and enhances cholesteryl ester transfer protein expression without affecting the liver X receptor α in HepG2 cells.
Cheng TJ; Lin SW; Chen CW; Guo HR; Wang YJ
Chem Biol Interact; 2016 Oct; 258():288-96. PubMed ID: 27622732
[TBL] [Abstract][Full Text] [Related]
20. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
